Fcpm III Services B.V
$750M 13F equity value
11 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Fcpm III Services B.V covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 8,490,353 | $288M | 38.3% |
| MPLT | MAPLIGHT THERAPEUTICS INC | 3,226,400 | $116M | 15.4% |
| DYN | DYNE THERAPEUTICS INC | 3,848,256 | $85M | 11.4% |
| VOR | VOR BIOPHARMA INC | 4,117,354 | $76M | 10.1% |
| DMRA | DAMORA THERAPEUTICS INC | 2,441,000 | $63M | 8.5% |
| REPL | REPLIMUNE GROUP INC | 2,808,368 | $31M | 4.1% |
| CBIO | CRESCENT BIOPHARMA INC. | 1,677,852 | $30M | 4.0% |
| AURA | AURA BIOSCIENCES INC | 4,053,775 | $29M | 3.8% |
| ENGN | ENGENE HOLDINGS INC | 9,632,561 | $17M | 2.2% |
| BCYC | BICYCLE THERAPEUTICS PLC | 3,468,430 | $15M | 2.0% |
Track Fcpm III Services B.V's 13F portfolio: $750M in reported holdings, 11 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}